Simple Summary Neuroendocrine neoplasms are divided into two groups: well-
differentiated neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas …

Introduction: Recently, there have been a number of advances in imaging pancreatic
neuroendocrine tumors (panNETs), as well as other neuroendocrine tumors (NETs), which …

Somatostatin receptor (SSTR) PET has demonstrated a significant improvement over
conventional imaging (CI) in patients with neuroendocrine tumors (NETs). SSTR PET should …

Our purpose was to investigate differences between PET/MRI and PET/CT in lesion
detection and classification in oncologic whole-body examinations and to investigate …

Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) arise from neuroendocrine
cells found throughout the gastrointestinal tract and islet cells of the pancreas. The incidence …

Recent developments in hybrid SPECT/CT systems and the use of cadmium-zinc-telluride
(CZT) detectors have improved the diagnostic accuracy of bone scintigraphy. These …

Pancreatic neuroendocrine neoplasms (panNENs) represent the second most common
pancreatic tumors. They are a heterogeneous group of neoplasms with varying clinical …

Neuroendocrine tumors (NETs) are rare neoplasms that emerge mainly from the GI tract,
pancreas and respiratory tract. The incidence of NETs has increased more than sixfold in the …

OBJECTIVE. The purpose of this article is to provide an update on clinical PET/MRI,
including current and develo** clinical indications and technical developments …

Abstract Background Neuroendocrine tumors (NETs) frequently overexpress somatostatin
receptors (SSTRs), which is the molecular basis for 68 Ga-DOTATOC positron-emission …